GlassScriptPhysician profile
Grant H Louie
NPI 1306013214
$3,560.57
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,573 · 2020: $1,578 · 2021: $58.81 · 2022: $219 · 2024: $132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $132.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $131.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Global Services, LLC | $1,500.00 | 2020 | |
| Amgen INC. | $364.38 | 2019-2024 | Krystexxa |
| Abbvie INC. | $350.47 | 2019-2022 | |
| Janssen Biotech, INC. | $195.17 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $142.78 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $133.97 | 2022 | |
| Ucb, INC. | $130.94 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $123.56 | 2019-2021 | |
| Lilly USA, LLC | $88.68 | 2019-2020 | |
| Pfizer INC. | $77.29 | 2019 | |
| Celgene Corporation | $74.63 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $62.29 | 2019 | |
| Glaxosmithkline, LLC. | $49.81 | 2019 | |
| Genentech USA, INC. | $35.03 | 2019 | |
| Merck Sharp & Dohme LLC | $34.42 | 2019-2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hikma Pharmaceuticals USA | $33.80 | 2019 | |
| Depuy Synthes Sales INC. | $30.28 | 2019 | |
| Sobi, INC | $28.66 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $28.44 | 2019 | |
| Horizon Therapeutics Plc | $28.40 | 2019 | |
| Alexion Pharmaceuticals, INC. | $19.84 | 2019 | |
| Radius Health, INC. | $15.76 | 2024 | Tymlos |
| Abbott Laboratories | $11.97 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grant Louie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.